Aurigene Oncology Limited

At Aurigene Oncology, Diwali is more than just a celebration - it’s a reflection of our spirit of creativity, camaraderie, and teamwork. This year, our Diwali festivities featured a Diya Decoration Competition and a bustling Flea Market, bringing festive cheer with handcrafted treasures and local delicacies that enriched the celebration. Here’s a glimpse of the celebrations... #LifeAtAurigene #Workplace #FestiveCelebration #Camaraderie

At Aurigene, we believe a great workplace is built on growth, innovation, and a deep commitment to making a difference. Our culture empowers every individual to reach their potential, collaborate meaningfully, and bring bold ideas to life. Hear from our colleague Swati Shrivastava, who shares what makes life at Aurigene inspiring - from the dynamic teamwork to our mission-driven projects and the personal and professional growth each of us experiences every day. #LifeAtAurigene #GreatPlaceToWork #Innovation #EmployeeExperience

Eager to engage with like-minded companies to explore partnering opportunities, with the common goal of bringing innovative therapeutics to patients across the globe. #AurigeneOncology #BioEurope #innovation #smallmolecules #clinical #preclinical #oncology #outlicensing Informa Connect

We are actively seeking talented individuals to join our team and make a meaningful impact. #hiring #joinourteam #AntibodyEngineering #AntibodyTherapeutics

October is Breast Cancer Awareness Month and ‘Awareness is the First Step to Prevention’ Let’s come together to raise awareness and advance progress in breast cancer research and care. Here are some ways to support the cause: 🎗 Get Screened: Early detection saves life. 🎗 Spread the word: Share authentic facts and resources. 🎗 Support Survivors: Offer your support to those currently battling breast cancer. At Aurigene Oncology Limited we stand with millions of women and men around the world in the fight against Breast Cancer. #BreastCancer #BreastCancerAwareness #WomensHealth #BreastCancerResearch #HealthyLiving #Cancer #CancerDetection #Oncology #Research

At Aurigene Oncology, we believe in working hard and celebrating harder! 🎉 Navrang 2024 was a celebration of 9 vibrant days of Navratri, with each day featuring a unique colour theme. Colleagues came together to enjoy fun, unity, and entertainment, creating memories that will last. The highlight of the event was an energetic Dandiya night setting the mood with lively beats🎶, making it a perfect end to a fantastic series of celebration. 🌸✨ #GreatPlaceToWork #camaraderie #LifeAtAurigene #AurigeneOncology

🎗 October is Breast Cancer Awareness Month and ‘Awareness Is The First Step To Prevention 🎗 🎗 Breast cancer touches the lives of so many whether through personal experiences or by supporting a loved one. Together we can make a difference by: 🌸 Raising awareness 🌸 Supporting research 🌸 Encouraging regular screenings 🎗 At Aurigene Oncology Limited we stand with millions of women and men around the world in the fight against Breast Cancer 🎗 #BreastCancer #BreastCancerAwareness #WomensHealth #BreastCancerResearch #HealthyLiving #Healthcare #Pharma #Biotech #Cancer #Oncology

We are at CPHI in Milan, Italy. Our team representing Dr. Reddy's Active Pharmaceutical Ingredients, formulations, Biologics, CRDMO Aurigene Pharmaceutical Services Limited and oncology drug discovery Aurigene Oncology Limited are present and happy to discuss how we can sustainably increase access to affordable and innovative medicines together. You can meet us at booth #24A41 from today until October 10th, from 9:00 am to 6:30 pm. See you there! #CPHI2024 #GoodHealthCantWait #WeAreDrReddys

We are pleased to announce Phase 1 results for Ribrecabtagene autoleucel (DRL-1801) from the SWASTH study – India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma. The study reported initial results from the first 8 patients. All 8 patients (100%) achieved clinical response, with 5/8 (62.5%) having achieved stringent complete response. With respect to safety, there were no high-grade events of Cytokine Release Syndrome (CRS) or neurotoxicity, in any of the patients. These results of Phase 1 were presented at the 21st annual meeting of the International Myeloma Society at Rio De Janeiro, Brazil, held recently. “The results from the trial in heavily pre-treated relapsed refractory myeloma patients are very exciting for us in India. We are thrilled with the data, as the drug could be transformative for Indian patients with myeloma” comments our CEO Dr. Murali Ramachandra. #CellTherapy #ClinicalTrials #CancerPipeline #OncologyPipeline #News #PharmaNews #PharmaIndustry #Innovation #Cancer #Oncology #BusinessNews https://lnkd.in/g6N5Tizv

We are proud to be recognized as one of the 2024 Best Companies for Women in India - Emerging Icons by Avtar & Seramount! 🏆 This prestigious recognition reaffirms our commitment to fostering a diverse and inclusive workplace where women are empowered to excel, innovate, and lead. A huge thank you to our incredible team for championing this journey, ensuring everyone feels empowered to contribute their unique perspectives! #AurigeneOncology #DiversityAndInclusion #WorkplaceRecognition #Champions